Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending HLTH 2023 event in Las Vegas (USA) from October 8th to 11th. HLTH 2023 is the preeminent event [...]
In today's world, antibiotic resistance and multi-resistant bacteria pose a challenge to modern medicine. Innovative therapies involving microbiota and treatments for infectious diseases offer a promising solution to address this issue. The diverse community of [...]
Claudio Hidalgo, CEO at Microviable, will be attending BioSpain 2023, one of the largest international biotechnology events in southern Europe, will take place from 26-28 September 2023 in Barcelona thanks to a coordinated collaboration of [...]
Microviable Therapeutics will be presenting at Farmaforum 2023 taking place on September 20th-21th at Madrid. The Microviable team will consist of Claudio Hidalgo, CEO of the company, and Noelia Martínez, R&D Director. Noelia Martínez will [...]
During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiome Post sat down with Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, to learn more about the donor-based microbiome therapeutic products research and [...]
Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]
Welcome David Ríos Covián, Director of Technology Development, on board. David obtained his BS in Biology (2010) and MS (2011) in Food Biotechnology at the University of Oviedo. In addition, he obtained his PhD (2016) [...]
Microviable Therapeutics is celebrating World Microbiome Day 2023! We share how important microbes are for the health of humans, animals, plants, oceans and the entire planet. Through increased awareness and education we can create a [...]
Microviable Therapeutics Research Scientist Pilar Manrique will be presenting at Microbiome Connect Europe 2023 taking place on July 5th-6th at Amsterdam. Pilar will discuss "A path to develop a donor-based microbiome therapeutic product". Microbiome Connect [...]
Microviable Therapeutics will be presenting at the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. Noelia Martínez, R&D Director, Pilar Manrique, Research Scientist and Marta F. Gosende, Research [...]